After the unceremonious exit from Brazil, indigenous vaccine maker Bharat Biotech is looking at an uncertain future in the United States. The US firm with which it had tied up to launch Covaxin in the foreign country, is now facing a class-action lawsuit in Pennsylvania.
#BharatBiotech #Ocugen #Covaxin #UnitedStates #Covid19 #Coronavirus #Vaccine
Dear Readers,
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
